MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

Subcutaneous emphysema (SE) is a recognized but rare complication of laparoscopic surgery, and orbital involvement is particularly unusual. We report a rare case of unilateral orbital SE following ...

The FDA rejected AstraZeneca's subcutaneous Saphnelo application, delaying U.S. approval until 2026, despite positive clinical trial results. The subcutaneous formulation allows self-administration, ...

Please provide your email address to receive an email when new articles are posted on . Knee crepitus was associated with osteoarthritis risk at 1-year post-ACL reconstruction. However, crepitus did ...

Excess belly fat poses serious health risks, including diabetes and heart disease. The article distinguishes between subcutaneous fat under the skin and dangerous visceral fat surrounding organs.

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

Intro: Cardiac tamponade is a common cause of obstructive shock, often necessitating urgent intervention. We delineate a rare case of cardiac tamponade and shock due to tension pneumomediastinum (TP).

In early October 2025, Merck announced FDA approval for a subcutaneous version of Keytruda and shared positive Phase 3 trial outcomes for both Keytruda in several cancer types and Winrevair in ...

Related video: The exercise change as effective as medication for knee pain Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well ...

Noisy knees after an ACL injury may raise fears of impending arthritis, but new research shows that these noises signal existing damage and not future decline, helping patients and clinicians separate ...

New research finds no link between having noisy knees and a future risk of joint problems in people recovering from knee surgery. Reading time 2 minutes Here’s some potential good news for runners or ...

The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...